Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation

Bone Marrow Transplantation

Volumn 48, Issue 12, 2013, Pages 1558-1561

  Casey, J ^a   Morris, K ^a   Narayana, M ^a   Nakagaki, M ^a   Kennedy, G A ^a,b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

allogeneic progenitor cell transplantation; parainfluenza virus; respiratory syncitial virus; ribavirin

Indexed keywords

RIBAVIRIN;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG DOSE ESCALATION; DRUG RESPONSE; DRUG TOLERANCE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; OUTCOME ASSESSMENT; PARAINFLUENZA VIRUS 3; PARAINFLUENZA VIRUS 3 INFECTION; PARAINFLUENZA VIRUS INFECTION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RETROSPECTIVE STUDY; SURVIVAL; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION;

ADMINISTRATION, ORAL; ADULT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PARAINFLUENZA VIRUS 3, HUMAN; PROGNOSIS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RESPIROVIRUS INFECTIONS; RETROSPECTIVE STUDIES; RIBAVIRIN; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84889566240     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2013.112     Document Type: Article

References (28)

1. Harrington RD, Hooton TM, Hackman RC, Storch GA, Osborne B, Gleaves CA et al. An outbreak of respiratory synsitial virus in a Bone Marrow transplant center. J Infect Dis 1992; 165: 987-993
2. Lewis VA, Champlin R, Englund J, Couch R, Goodrich JM, Rolston K et al. Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipeints. Clin Infect Dis 1996; 23: 1033-1037 (Pubitemid 26367489)
3. Nichols WG, Gooley T, Boeckh M. Community-Acquired respiratory synsitial virus and parainfluenza virus infections after hematopoetic stem cell transplantation: The Fred Hutchinson Cancer Research Center experience. Biol Blood Bone Marrow Trans 2001; 7: 11s-15s. (Pubitemid 33734763)
4. Wendt CW, Weisdorf DJ, Jordan C, Balfour HH, Hertz MI. Parainfluenza virus respiratory infection after bone marrow transplantation. NEJM 1992; 326: 921-926
5. Preston SL, Drusano GL, Glue P, Nash J, Gupta SK, McNamara P. Pharmacokinetics and absolute bioavailability of ribavirin in healthy volunteers as determined by stable-isotope methodology. Antimicrob Chemother 1999; 43: 2451-2456 (Pubitemid 29471226)
6. Boeckh M, Englund J, Li Y, Miller C, Cross A, Fernandez H et al. Randomized controlled multicenter trial of aerosolized ribavirin for respiratory synsitial virus upper respiratory tract infection in hematopoetic cell transplant recipients. Clin Infect Dis 2007; 44: 245-249 (Pubitemid 46079989)
7. Bowden RA. Respiratory virus infections after marrow transplant: The Fred Hutchinson Cancer Research Center Experience. Am J Med 1997; 102: 27-30
8. Sparrelid E, Ljunman P, Ekelof-Andstrom E, Aschan J, Ringden O, Winiarski J et al. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections. Bone Marrow Transplant 1997; 19: 905-908 (Pubitemid 27217657)
9. Shah JN, Chemaly RF. Management of RSV infections in adult recipeints of hemopoetic stem cell transplant. Blood 2011; 117: 2755-2763
10. Lambert SB, Whiley DM, O'Neill NT, Andrews EC, Canavan FM, Bletchly C et al. Comparing nose-Throat swabs and nasopharyngeal aspirates from children with symptoms for respiratory virus identification using real-Time polymerase chain reaction. Pediatrics 2008; 122: E615-e620
11. Hisrsh HH, Martino R, Ward KN, Boeckh M, Einsele H, Ljungman P. Fourth European conference on infections in leukaemia (ECIL-4): Guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus and coronavirus. Clin Infect Dis 2013; 56: 256-266
12. Avetisyan G, Mattsson J, Sparrelid E, Ljungman P. Respitarory syncytial virus infection in receipients of allogenic stem cell transplantation: A retropsective study of the incidence, clinical features and outcome. Transplantation 2009; 88: 1222-1226
13. Chemaly RF, Hanmod SS, Rathod DB, Ghantoji SS, Jiang Y, Doshi A et al. The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukaemia or recipients of hematopoietic stem cell transplantation. Blood 2012; 19: 2738-2748
14. Elizaga J, Olivarria E, Apperley JF, Goldman JM, Ward KN. Parainfluenza virus 3 infection after stem cell transplant: Relevance of outcome of rapid diagnosis and ribavirin treatment. Clin Infect Dis 2001; 32: 413-418 (Pubitemid 32173627)
15. Hassan IA, Chopra R, Swindell R, Mutton KJ. Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: The Christie hospital experience. Bone Marrow Transplant 2003; 32: 73-77 (Pubitemid 36850283)
16. Hodson A, Kasliwal M, Streetly M, MacMahon E, Raj K. A parainfluenza-3 outbreak in SCT unit: Sepsis with multi-organ failure and multiple co-pathogens are associated with increased mortality. Bone Marrow Transplant 2011; 46: 1545-1550
17. Khanna N, Widmer A, Decker M, Steffen I, Halter J, Heim D et al. Respiratory synsitial virus infection in patients with hematological disease: Single-centre study and review of the literature. Clin Infect Dis 2008; 46: 402-412 (Pubitemid 351263523)
18. Ljungman P, Ward KN, Crooks BNA, Parker A, Martino R, Shaw PJ et al. Respiratory virus infections after stem cell transplantation: A prospective study from the infectious diseases working party of the European group for blood and marrow transplantation. Bone Marrow Transplant 2001; 28: 479-484 (Pubitemid 33069626)
19. Machado CM, Boas LSV, Mendes AVA, Santos MFM, da Rocha IF, Sturaro D et al. Low mortality rates related to respiratory virus infections after bone marrow transplantation. Bone Marrow Transplant 2003; 31: 695-700 (Pubitemid 36553480)
20. Maziarz RT, Sridharan P, Slater S, Meyers G, Post M, Erdman D et al. Control of an outbreak of human parainfluenza virus 3 in hematopoetic stem cell transplant recipients. Biol Blood Marrow Transplant 2010; 16: 192-198
21. Nichols WG, Corey L, Gooley T, Davis C, Boeckh M. Parainfluenza virus infections after hematopoetic stem cell transplantation: Risk factors, response to antiviral therapy, and effect on transplant outcome. Blood 2001; 98: 573-578
22. Chakrabarti S, Collingham KE, Holder K, Oyaide S, Pillay D, Milligan DW. Parainfluenza 3 virus type 3 infections in hematopoetic stem cell transplant recipients: Response to ribavirin therapy. Clin Infect Dis 2000; 31: 1516-1518
23. Ariza-Heredia EJ, Fishman JE, Cleary T, Smith L, Razonable RR, Abbo L et al. Clinical and radiological features of respiratory syncytical virus in solid organ transplant recipients: A single-center experience. Transplant Infect Dis 2012; 14: 64-71
24. Glanville AR, Scott AI, Morton JM, Aboyoun CL, Plitt ML, Carter IW et al. Intravenous ribavirin is a safe and cost effective treatment for respiratory syncytial virus infection after lung transplantation. J Heart Lung Transplant 2005; 24: 2114-2119 (Pubitemid 41814734)
25. Li L, Avery R, Budev M, Mossad S, Danziger-Isakov L. Oral virus inhaled ribavirin therapy for respiratory syncytical virus infection after lung transplantation. J Heart Lung Transplant 2012; 31: 839-844
26. Pelaez A, Lyon GM, Force SD, Ramiez AM, Neujahr DC, Foster M. Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection. J Heart Lung Transplant 2009; 28: 67-71
27. Chakrabarti S, Collingham KE, Holder K, Fegan CD, Osman H, Milligan DW. Preemptive oral ribivirin therapy for paramyxomavirus infections after haematopoietic stem cell transplant: A pilot study. Bone Marrow Transplant 2001; 28: 759-763 (Pubitemid 33085568)
28. Buckingham SC, Jafri HS, Bush AJ, Carubelli C, Sheerman P, Hardy RD et al. A randomised, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: Effects on RSV quantity and clinical outcome. J Infect Dis 2002; 185: 1222-1228 (Pubitemid 34439128)